FAQs | How to Order | Contact Us | Prescribing Information | Important Safety Information
 Register  |  Login

First responders face unique risks every day. At Meridian Medical Technologies™, Inc., a subsidiary of King Pharmaceuticals®, Inc., we're committed to helping you prepare for significant risks that sometimes get overlooked. That's why we developed DuoDote™, the next-generation replacement for the Mark I™ Kit that optimizes response to organophosphorus nerve agent and organophosphorus insecticide poisoning. [1]

DuoDote.com is here to provide you with information, resources, and some important questions to consider about your community's preparedness. As features are added to the site, you will experience a new type of gathering place for the community of first responders and managers to obtain information and read about the unique challenges and risks that only you can truly understand.

Please register today to receive updates on new resources available through DuoDote.com and to gain access to members-only areas of the site. Registration for DuoDote.com is quick, easy, and free. For a limited time, each registered user will receive a free DuoDote Trainer. Click here to register today.

The DuoDote™ Auto-Injector (atropine 2.1 mg/0.7 mL and pralidoxime chloride 600 mg/2 mL) is indicated for the treatment of poisoning by organophosphorus nerve agents as well as organophosphorus insecticides.

IMPORTANT SAFETY INFORMATION

The DuoDote Auto-Injector is intended as an initial treatment of the symptoms of organophosphorus insecticide or nerve agent poisonings; definitive medical care should be sought immediately. The DuoDote Auto-Injector should be administered by Emergency Medical Services personnel who have had adequate training in the recognition and treatment of nerve agent or insecticide intoxication.

Individuals should not rely solely upon agents such as atropine and pralidoxime to provide complete protection from chemical nerve agents and insecticide poisoning. Primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective garments including masks designed specifically for this use. Evacuation and decontamination procedures should be undertaken as soon as possible. Medical Personnel assisting evacuated victims of nerve agent poisoning should avoid contaminating themselves by exposure to the victim's clothing.

In the presence of life-threatening poisoning by organophosphorus nerve agents or insecticides, there are no absolute contraindications to the use of the DuoDote Auto-Injector. When symptoms of poisoning are not severe, DuoDote Auto-Injector should be used with extreme caution in people with heart disease, arrhythmias, recent myocardial infarction, severe narrow angle glaucoma, pyloric stenosis, prostatic hypertrophy, significant renal insufficiency, chronic pulmonary disease, or hypersensitivity to any component of the product.

Please click here to view full prescribing information for DuoDote.

Site Map | References | Copyright | Privacy Policy | Terms of Use | About Meridian


DuoDote Auto-Injector, the DuoDote Logo, Mark I Kit, and BinaJect are trademarks of Meridian Medical Technologies™, Inc., a wholly owned subsidiary of King Pharmaceuticals®, Inc. Copyright ® 2010 Meridian Medical Technologies™, Inc., a wholly owned subsidiary of King Pharmaceuticals®, Inc. All rights reserved. MMT6193 06/2009